Pear therapeutics twitter
WebApr 7, 2024 · Pear’s apps guide users through behavioral therapy. getty P ear Therapeutics, which has three FDA-cleared prescription apps to help treat substance use disorder and … Web22 hours ago · Pear Therapeutics (NASDAQ: PEAR) stock is falling on Friday after the company’s recent bankruptcy filing continues to weigh on its shares. Pear Therapeutics announced its bankruptcy filing while ...
Pear therapeutics twitter
Did you know?
WebJun 22, 2024 · Pear Therapeutics, which has three FDA-authorized apps to treat psychiatric disorders, plans to go public in a $1.6 billion special purpose acquisition corporation, or SPAC deal, the company... WebApr 10, 2024 · Shares of Pear Therapeutics Inc. slid nearly 39% on Monday and a hit an all-time low after the developer of prescription digital therapeutics filed for Chapter 11 …
WebJan 3, 2024 · Jan. 3, 2024, 11:25 AM Pear Therapeutics Inc (NASDAQ:PEAR) is trading higher Monday following positive analyst coverage from BTIG. BTIG analyst Marie Thibault initiated coverage on Pear...
WebPear Therapeutics. The leader in Prescription Digital Therapeutics. At Pear, our mission is clear: we are pioneers in PDTs. Our cross-functional team operates at the intersection of … WebMar 31, 2024 · Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it is engaged in a process to explore strategic alternatives to maximize shareholder value.
WebNov 15, 2024 · Pear Therapeutics, a Boston-based maker of app-based programs that are prescribed to treat insomnia and substance use disorder, will cut 22% of its staff in a bid to reduce costs amid a “ challenging macroeconomic environment.”
WebFeb 27, 2024 · Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and … law offices of sima salekWebMar 17, 2024 · Published: Mar 17, 2024 BOSTON-- ( BUSINESS WIRE )-- Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it is engaged in a process to explore strategic alternatives to maximize shareholder … law offices of sima aghaiWebMar 17, 2024 · Pear Therapeutics (PEAR – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares closed today at $0.39. The company’s shares ... law offices of soheila s. azizi \u0026 associatesWebApr 3, 2024 · Apr. 3, 2024, 03:55 AM In a report released today, Marie Thibault from BTIG maintained a Hold rating on Pear Therapeutics ( PEAR – Research Report ). The company’s shares closed last Friday... law offices of soda \u0026 greenbergWebMar 17, 2024 · BOSTON--(BUSINESS WIRE)--Mar. 17, 2024-- Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software … kappa books publishersWebMar 17, 2024 · BOSTON -- (BUSINESS WIRE)--Mar. 17, 2024-- Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it is engaged in a process to explore strategic alternatives to maximize shareholder value. kappa books publishers llcWebPear Therapeutics 18,057 followers on LinkedIn. The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent … kappa by the sea